Patients With GH Deficiency Due To Nonfunctioning Pituitary Adenoma May Experience Excessive Morbidity Due To Cerebral Infarction, Sepsis Regardless Of Whether They Received Long-Term GH Therapy.

reports, “Patients with growth hormone [GH] deficiency due to nonfunctioning pituitary adenoma experienced excessive morbidity due to cerebral infarction and sepsis regardless of whether they received long-term GH therapy, whereas treatment was associated with a normal incidence of type 2 diabetes [T2D], despite higher” body mass index “and more severe hypopituitarism in treated patients,” researchers concluded in a 426-patient study. The findings were published in the European Journal of Endocrinology. https://www.healio.com/endocrinology/neuroendocrinology/news/in-the-journals/%7B0739a3a3-f592-4352-93f0-2ee5b5a89251%7D/no-association-between-long-term-gh-replacement-comorbidities-in-nonfunctioning-pituitary-adenoma